COHERUS BIOSCIENCES, INC., as Issuer, the Guarantors from time to time party hereto, as Guarantors AND HealthCare Royalty Partners III, L.P., MX II Associates LLC, KMG Capital Partners, LLC AND KKR Biosimilar L.P., each as an Investor Senior...Convertible Note Purchase Agreement • February 29th, 2016 • Coherus BioSciences, Inc. • Biological products, (no disgnostic substances) • New York
SENIOR CONVERTIBLE NOTE PURCHASE AGREEMENT (this “Agreement”), dated as of February 29, 2016 (the “Closing Date”) among Coherus BioSciences, Inc., a Delaware corporation, as Issuer (the “Company”), InteKrin Therapeutics Inc., a Delaware corporation, and Coherus Intermediate Corp., a Delaware corporation, as the Guarantors (as defined below), and HealthCare Royalty Partners III, L.P., MX II Associates LLC, KMG Capital Partners, LLC and KKR Biosimilar L.P. (each, an “Investor,” and, collectively, the “Investors”).
